Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort

MT Newswires Live06-18

Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort Clover Biopharmaceuticalsâ (HKG:2197) phase 1 results for its bivalent RSV vaccine candidate SCB-1019 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2444481959?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-18 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2444481959","market":"sh","top_or_hot":-1,"title":"Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort","media":"MT Newswires Live","content":"<div>\n<p>Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort Clover Biopharmaceuticalsâ (HKG:2197) phase 1 results for its bivalent RSV vaccine candidate SCB-1019 ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-18 20:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort Clover Biopharmaceuticalsâ (HKG:2197) phase 1 results for its bivalent RSV vaccine candidate SCB-1019 ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4547","symbol_name":"WSB热门概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2444481959","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2444481959","pubTimestamp":1718712222,"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort Clov","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4547":"WSB热门概念","BK4568":"美国抗疫概念","HKD":"尚乘数科","NVAX":"诺瓦瓦克斯医药","BK4023":"应用软件","BK4585":"ETF&股票定投概念","02197":"三叶草生物-B","CHRT.UK":"COHORT","BK1161":"生物科技","BK4139":"生物科技","BK4526":"热门中概股","BK4588":"碎股","BK5131":"航天航空与国防"},"translate_title":"Clover Biopharmaceuticals的SCB-1019在老年人和老年人队列中显示出积极的结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1,"CHRT.UK":1,"HKD":1,"NVAX":1},"content_text":"Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort Clover Biopharmaceuticalsâ (HKG:2197) phase 1 results for its bivalent RSV vaccine candidate SCB-1019 for older adult and elderly cohort, were positive and were consistent with the positive results in the young adult cohort from earlier this year, a Tuesday filing with the Hong Kong Exchange said. The drugâs immunogenicity results were comparable or better as compared with other protein subunit RSV PreF vaccines. The drugâs safety test results showed that the drug was generally well-tolerated without any serious adverse events indicating that the drug has a better and more favorable safety & reactogenicity profile as compared to other vaccines. Price (HKD): $0.37, Change: $, Percent Change: %","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2444481959"}

Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort

Comments

Clover Biopharmaceuticalsâ SCB-1019 Shows Positive Results for Older Adult and Elderly Cohort